The forecasted mortality from bladder malignant neoplasms among females in Canada indicates a steady increase from 2024 to 2028, beginning at 709 deaths in 2024 and rising to 745 by 2028. Compared to 2023 data, the mortality projection for 2024 marks the starting point of forecasted values.
Future trends to watch for include potential impacts of advancing early diagnosis technologies, enhanced treatment protocols, and health policy changes aimed at reducing risk factors. Monitoring demographic shifts and healthcare accessibility in various regions could also be crucial in anticipating changes in mortality trends.
